126 related articles for article (PubMed ID: 26874673)
1. Compliance with carbapenem guidelines in a university hospital.
Van Hollebeke M; Chapuis C; Bernard S; Foroni L; Stahl JP; Bedouch P; Pavese P
Med Mal Infect; 2016 Mar; 46(2):72-8. PubMed ID: 26874673
[TBL] [Abstract][Full Text] [Related]
2. Assessing the relevance of carbapenem prescriptions by an antibiotic stewardship team.
Perron J; Baldolli A; Isnard C; de La Blanchardière A; Saint-Lorant G
Med Mal Infect; 2020 Jun; 50(4):346-351. PubMed ID: 31257064
[TBL] [Abstract][Full Text] [Related]
3. Audit of carbapenem prescriptions comparing 2 assessment periods.
Lefébure A; Papy E; Rioux C; Diamantis S; Armand-Lefèvre L; Longuet P; Lescure FX; Wolff M; Arnaud P; Lucet JC
Med Mal Infect; 2015 Jul; 45(7):273-8. PubMed ID: 26047686
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem prescriptions: Compliance with guidelines in a pediatric hospital.
Cebron C; Smiljkovic M; Percheron L; Caspar Y; Arata-Bardet J; Mortamet G; Martinod M
Arch Pediatr; 2023 Jul; 30(5):302-306. PubMed ID: 37286425
[TBL] [Abstract][Full Text] [Related]
5. [Carbapenem antibiotics in hospitalised paediatric patients. Adherence to a therapeutic protocol].
Montesinos-Sanchis E; Moraga-Llop FA; Soler-Palacín P; Oliveras-Arenas M; Larrosa Escartín MN; Martínez Gómez X; Figueras-Nadal C
Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):647-53. PubMed ID: 24355607
[TBL] [Abstract][Full Text] [Related]
6. Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study.
Poline J; Postaire M; Parize P; Pilmis B; Bille E; Zahar JR; Frange P; Cohen JF; Lortholary O; Toubiana J
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1039-1048. PubMed ID: 33389261
[TBL] [Abstract][Full Text] [Related]
7. Proper use of carbapenems: Role of the infectious disease specialist.
Issa N; Pedeboscq S; Le Quellec F; Bessède E; Vandenhende M; Bonnet F; Morlat P; Camou F
Med Mal Infect; 2016 Feb; 46(1):10-3. PubMed ID: 26698014
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program.
Sadyrbaeva-Dolgova S; Aznarte-Padial P; Jimenez-Morales A; Expósito-Ruiz M; Calleja-Hernández MÁ; Hidalgo-Tenorio C
J Infect Public Health; 2020 Apr; 13(4):558-563. PubMed ID: 31685404
[TBL] [Abstract][Full Text] [Related]
9. Carbapenem stewardship program in a French university children's hospital.
Pauquet E; Coppry M; Sarlangue J; Rogues AM
Arch Pediatr; 2021 Nov; 28(8):621-625. PubMed ID: 34686425
[TBL] [Abstract][Full Text] [Related]
10. Appropriate use of carbapenems in the Besançon university hospital.
Jary F; Kaiser JD; Henon T; Leroy J; Patry I; Blasco G; Limat S
Med Mal Infect; 2012 Oct; 42(10):510-6. PubMed ID: 23044084
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis.
Sadyrbaeva-Dolgova S; Aznarte-Padial P; Pasquau-Liaño J; Expósito-Ruiz M; Calleja Hernández MÁ; Hidalgo-Tenorio C
Int J Infect Dis; 2019 Aug; 85():80-87. PubMed ID: 31075508
[TBL] [Abstract][Full Text] [Related]
12. Enterobacteriaceae bacteremia: risk factors for ESBLPE.
Neulier C; Birgand G; Ruppé É; Armand-Lefèvre L; Lolom I; Yazdanpanah Y; Lucet JC; Andremont A
Med Mal Infect; 2014 Jan; 44(1):32-8. PubMed ID: 24321202
[TBL] [Abstract][Full Text] [Related]
13. [Available carbapenems: Properties and differences].
Martínez MJ; García MI; Sánchez EG; Sánchez JE
Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():53-64. PubMed ID: 21130931
[TBL] [Abstract][Full Text] [Related]
14. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
[TBL] [Abstract][Full Text] [Related]
15. Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.
de La Blanchardière A; Dargère S; Guérin F; Daurel C; Saint-Lorant G; Verdon R; Cattoir V
Med Mal Infect; 2015 May; 45(5):169-72. PubMed ID: 25845927
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prescription in intensive care units in Latin America.
Curcio DJ;
Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia.
Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H
J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781
[TBL] [Abstract][Full Text] [Related]
18. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
Ramsamy Y; Muckart DJ; Han KS
S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem use in French hospitals: A nationwide survey at the patient level.
Gauzit R; Pean Y; Alfandari S; Bru JP; Bedos JP; Rabaud C; Robert J; ; ;
Int J Antimicrob Agents; 2015 Dec; 46(6):707-12. PubMed ID: 26508585
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Chiu S; Huang YC; Lien RI; Chou YH; Lin TY
Acta Paediatr; 2005 Nov; 94(11):1644-9. PubMed ID: 16303704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
